Related Experiment Video
Updated: Apr 21, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Hereditary thyroid cancer syndromes and genetic testing
Kathryn J Rowland1, Jeffrey F Moley
1Division of Endocrine and Oncologic Surgery, Barnes Jewish Hospital, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
This review covers hereditary medullary thyroid cancer (MTC) and nonmedullary thyroid cancer (NMTC), detailing their genetics, diagnosis, and surgical treatment. It highlights innovations and debates, offering management recommendations for these inherited thyroid conditions.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Hereditary thyroid cancers, including medullary thyroid cancer (MTC) and nonmedullary thyroid cancer (NMTC), represent significant clinical challenges.
- Understanding the genetic underpinnings is crucial for diagnosis and management.
Purpose of the Study:
- To provide a comprehensive review of hereditary MTC and NMTC.
- To discuss current diagnostic and therapeutic strategies, including surgical approaches.
- To highlight areas of ongoing research and clinical debate.
Main Methods:
- Literature review focusing on genetics, clinical diagnosis, evaluation, and surgical management.
- Analysis of current innovations and controversial aspects in the field.
- Synthesis of information to formulate management recommendations.
Main Results:
- Detailed overview of genetic factors associated with hereditary MTC and NMTC.
- Discussion of diagnostic criteria and evaluation protocols.
- Exploration of surgical techniques and their outcomes.
- Identification of key areas of innovation and debate in management.
Conclusions:
- Effective management of hereditary thyroid cancers requires a multidisciplinary approach.
- Genomic advancements are transforming diagnosis and treatment strategies.
- Further research is needed to resolve current clinical debates and optimize patient care.
Related Concept Videos
Cancer Prevention
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
The Retinoblastoma Gene
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes

